AARDEX still confirms its leading position in the B2B medication adherence market, closing steadily more new deals with Pharma Companies, Biotech’s, Excellence Centers and Universities, over 30 countries in 2018.
Breaking News
AARDEX Group Partners with Industry Leaders on DiMe’s Digital Medicine Society’s V3+ Framework Project to Enhance Usability of DHTs
Extending the Verification, Analytical Validation and Clinical Validation (V3+) Framework Project will ensure digital clinical measures and products meet the needs of larger audiences. Liege, Belgium- May 3, 2023: Adherence specialists AARDEX Group is proud to announce its partnership with other industry leaders
Gemma Telfer
May 3, 2023
